TANDEM DIABETES CARE INC (TNDM) Stock Income Statement
NASDAQ:TNDM - Nasdaq - US8753722037 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 982.95M | 940.20M | 747.72M | 801.20M | 702.80M | |||
| Cost Of Goods | 469.64M | 450.63M | 380.03M | 388.20M | 326.60M | |||
| Gross Profit | 513.31M | 489.57M | 367.69M | 413.00M | 376.20M | |||
| Operating Expenses | 605.25M | 588.70M | 522.17M | 505.90M | 353.50M | |||
| Research and Development | 200.57M | 198.88M | 169.67M | 170.20M | 92.10M | |||
| Selling, General, and Administrative Expenses | 404.68M | 389.82M | 352.50M | 335.70M | 261.50M | |||
| Operating Income | -91.94M | -99.13M | -154.48M | -92.80M | 22.70M | |||
| Interest Income/Expense | 3.90M | 8.53M | 12.98M | 0.00 | -6.80M | |||
| Non Recurring Items | -86.38M | -1.27M | -78.75M | N/A | N/A | |||
| Income Before Taxes | -174.43M | -91.87M | -220.25M | -92.90M | 15.90M | |||
| Income Tax | 9.44M | 4.16M | 2.36M | 1.70M | 300.00K | |||
| Net Income | -183.87M | -96.03M | -222.61M | -94.60M | 15.60M | |||
| EBITDA | -75.07M | -82.52M | -138.76M | -78.50M | 36.50M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.78 | -1.47 | -3.43 | -1.47 | 0.24 | |||
| Non GAAP EPS | -1.48 | -1.45 | -3.12 | -0.99 | 0.23 | |||
| Statistics | ||||||||
| Gross Profit Margin | 52.22% | 52.07% | 49.17% | 51.55% | 53.53% | |||
| Profit Margin | -18.71% | -10.21% | -29.77% | -11.81% | 2.22% | |||
| Operating Profit Margin | -9.35% | -10.54% | -20.66% | -11.58% | 3.23% | |||
All data in USD